Targeting tumor hypoxia with stimulus-responsive nanocarriers in overcoming drug resistance and monitoring anticancer efficacy.

[1]  Jianqing Gao,et al.  MMP-2-Sensitive HA End-Conjugated Poly(amidoamine) Dendrimers via Click Reaction To Enhance Drug Penetration into Solid Tumor. , 2017, ACS applied materials & interfaces.

[2]  T. Xia,et al.  Multifunctional polycationic photosensitizer conjugates with rich hydroxyl groups for versatile water-soluble photodynamic therapy nanoplatforms. , 2017, Biomaterials.

[3]  Zhuxian Zhou,et al.  Esterase‐Activated Charge‐Reversal Polymer for Fibroblast‐Exempt Cancer Gene Therapy , 2016, Advanced materials.

[4]  Tsung-Ying Yang,et al.  Hypoxia can impair doxorubicin resistance of non-small cell lung cancer cells by inhibiting MRP1 and P-gp expression and boosting the chemosensitizing effects of MRP1 and P-gp blockers , 2016, Cellular Oncology.

[5]  Shiladitya Sengupta,et al.  Reporter nanoparticle that monitors its anticancer efficacy in real time , 2016, Proceedings of the National Academy of Sciences.

[6]  Jun Wang,et al.  Stimuli-responsive clustered nanoparticles for improved tumor penetration and therapeutic efficacy , 2016, Proceedings of the National Academy of Sciences.

[7]  Jianbin Tang,et al.  Fusogenic Reactive Oxygen Species Triggered Charge‐Reversal Vector for Effective Gene Delivery , 2016, Advanced materials.

[8]  David J. Mooney,et al.  Biomaterials and emerging anticancer therapeutics: engineering the microenvironment , 2015, Nature Reviews Cancer.

[9]  V. Ntziachristos,et al.  Monoclonal antibody-targeted PEGylated liposome-ICG encapsulating doxorubicin as a potential theranostic agent. , 2015, International journal of pharmaceutics.

[10]  Sharon Gerecht,et al.  Hydrogels to model 3D in vitro microenvironment of tumor vascularization. , 2014, Advanced drug delivery reviews.

[11]  Bin Liu,et al.  Mitochondria-targeted cancer therapy using a light-up probe with aggregation-induced-emission characteristics. , 2014, Angewandte Chemie.

[12]  Youqing Shen,et al.  Integration of Nanoassembly Functions for an Effective Delivery Cascade for Cancer Drugs , 2014, Advanced materials.

[13]  W. El-Deiry,et al.  HIF-1 signaling in drug resistance to chemotherapy. , 2014, Current medicinal chemistry.

[14]  Igor L. Medintz,et al.  Multifunctional liquid crystal nanoparticles for intracellular fluorescent imaging and drug delivery. , 2014, ACS nano.

[15]  S. Sollott,et al.  Mitochondrial reactive oxygen species (ROS) and ROS-induced ROS release. , 2014, Physiological reviews.

[16]  Taeghwan Hyeon,et al.  Multifunctional tumor pH-sensitive self-assembled nanoparticles for bimodal imaging and treatment of resistant heterogeneous tumors. , 2014, Journal of the American Chemical Society.

[17]  A. Weeraratna,et al.  Bisphosphonamidate Clodronate Prodrug Exhibits Selective Cytotoxic Activity against Melanoma Cell Lines , 2013, Molecular Cancer Therapeutics.

[18]  K. Morokuma,et al.  Development of azo-based fluorescent probes to detect different levels of hypoxia. , 2013, Angewandte Chemie.

[19]  Ameya R. Kirtane,et al.  Exploiting nanotechnology to overcome tumor drug resistance: Challenges and opportunities. , 2013, Advanced drug delivery reviews.

[20]  A. Shakhbazau,et al.  Poly(amidoamine) dendrimer complexes as a platform for gene delivery , 2013, Expert opinion on drug delivery.

[21]  R. Jain,et al.  Strategies for advancing cancer nanomedicine. , 2013, Nature materials.

[22]  M. Dewhirst,et al.  Tumor cells upregulate normoxic HIF-1α in response to doxorubicin. , 2013, Cancer research.

[23]  Anzar Khan,et al.  Enzyme sensitive synthetic polymer micelles based on the azobenzene motif. , 2013, Journal of the American Chemical Society.

[24]  R. Jain,et al.  Challenges and key considerations of the enhanced permeability and retention effect for nanomedicine drug delivery in oncology. , 2013, Cancer research.

[25]  Linyong Zhu,et al.  Highly Discriminating Photorelease of Anticancer Drugs Based on Hypoxia Activatable Phototrigger Conjugated Chitosan Nanoparticles , 2013, Advanced materials.

[26]  Jinming Hu,et al.  Enzyme-responsive polymeric assemblies, nanoparticles and hydrogels. , 2012, Chemical Society reviews.

[27]  Lin Zhu,et al.  Matrix metalloprotease 2-responsive multifunctional liposomal nanocarrier for enhanced tumor targeting. , 2012, ACS nano.

[28]  Lei Xu,et al.  Normalization of the vasculature for treatment of cancer and other diseases. , 2011, Physiological reviews.

[29]  Triantafyllos Stylianopoulos,et al.  Delivery of molecular and nanoscale medicine to tumors: transport barriers and strategies. , 2011, Annual review of chemical and biomolecular engineering.

[30]  W. Wilson,et al.  Targeting hypoxia in cancer therapy , 2011, Nature Reviews Cancer.

[31]  R. Mahato,et al.  Targeted delivery of siRNA to hepatocytes and hepatic stellate cells by bioconjugation. , 2010, Bioconjugate chemistry.

[32]  Tetsuo Nagano,et al.  Hypoxia-sensitive fluorescent probes for in vivo real-time fluorescence imaging of acute ischemia. , 2010, Journal of the American Chemical Society.

[33]  Warren C W Chan,et al.  Mediating tumor targeting efficiency of nanoparticles through design. , 2009, Nano letters.

[34]  M. Celeste Simon,et al.  The impact of O2 availability on human cancer , 2008, Nature Reviews Cancer.

[35]  Sunita Yadav,et al.  Multi-functional nanocarriers to overcome tumor drug resistance. , 2008, Cancer treatment reviews.

[36]  G. Semenza,et al.  Hypoxia-induced resistance to anticancer drugs is associated with decreased senescence and requires hypoxia-inducible factor-1 activity , 2008, Molecular Cancer Therapeutics.

[37]  Enrico Drioli,et al.  Mass transfer and metabolic reactions in hepatocyte spheroids cultured in rotating wall gas-permeable membrane system. , 2007, Biomaterials.

[38]  P. Vaupel,et al.  Hypoxia in cancer: significance and impact on clinical outcome , 2007, Cancer and Metastasis Reviews.

[39]  T. Minko,et al.  A novel cancer therapy: combined liposomal hypoxia inducible factor 1 alpha antisense oligonucleotides and an anticancer drug. , 2004, Biochemical pharmacology.

[40]  M. Salgaller.  Technology evaluation: bevacizumab, Genentech/Roche. , 2003, Current opinion in molecular therapeutics.

[41]  J. M. Harris,et al.  Effect of pegylation on pharmaceuticals , 2003, Nature Reviews Drug Discovery.

[42]  G. Dellaire,et al.  The Zebrafish Xenograft Platform: Evolution of a Novel Cancer Model and Preclinical Screening Tool. , 2016, Advances in experimental medicine and biology.

[43]  C. M. Roth,et al.  Nanoscale drug delivery systems for enhanced drug penetration into solid tumors: current progress and opportunities. , 2012, Critical reviews in biomedical engineering.

[44]  Danli Wu,et al.  Hypoxic tumors and their effect on immune cells and cancer therapy. , 2010, Methods in molecular biology.

[45]  W. G. Levine,et al.  A novel application of cyclic voltammetry for direct investigation of metabolic intermediates in microsomal azo reduction. , 1991, Chemical research in toxicology.